Quietidon en es it fr

Quietidon Brand names, Quietidon Analogs

Quietidon Brand Names Mixture

  • No information avaliable

Quietidon Chemical_Formula

C20H23NS

Quietidon RX_link

No information avaliable

Quietidon fda sheet

Quietidon msds (material safety sheet)

Quietidon Synthesis Reference

No information avaliable

Quietidon Molecular Weight

309.469 g/mol

Quietidon Melting Point

< 25 oC

Quietidon H2O Solubility

Soluble as HCl salt

Quietidon State

Liquid

Quietidon LogP

5.7

Quietidon Dosage Forms

Tablets (oral, 1 mg)

Quietidon Indication

Used for the symptomatic treatment of parkinsonism.

Quietidon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Quietidon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Quietidon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Quietidon Patient Information

Quietidon Organisms Affected

Humans and other mammals